Abstract
Objective To investigate the clinical efficacy of traditional Chinese medicine combined with transhepatic arterial chemotherapy and embolization(TACE)in the treatment of hepatocellular carcinoma(HCC). Methods A retrospective study was performed on 122 cases of patient with HCC who were treated with TACE from December 2013 to December 2018.According to the treatment plan, all patients were divided into the chemotherapy group and the combined group of traditional Chinese medicine.There were 59 cases in the chemotherapy group, including 30 male cases and 29 female cases.The age range was 34 to 74 years, aged(59.4±9.6)years.There were 63 patients in the combined group of traditional Chinese medicine, including 35 males and 28 females.The age range was 33 to 70 years, aged(60.8±8.4)years.Patients in the chemotherapy group were treated with TACE, and patients in the Chinese medicine combination group were treated with postoperative Chinese medicine combination on the basis of the chemotherapy group, and the clinical therapeutic effects and adverse reactions of the two groups were compared and analyzed. Results Partial remission[71.4%(45/63)] and lesion stability[25.4%(16/63)] of patients in the TCM combination group were significantly higher than those in the chemotherapy group[64.4%(38/59)and 23.7%(14/59)], with statistically significant differences(P 0.05). Conclusion TACE combined with traditional Chinese medicine can improve the treatment efficiency, and does not increase the incidence of adverse reactions, which can be used as a treatment for liver cancer patients. Key words: Hepatocellular carcinoma; Transhepatic arterial chemotherapy and embolization; Traditional Chinese medicine
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
